Search research articles
Contact Us
Filters
Showing results (1-10 of 63) with videos related to
Page
of 7
Sort By:
Current Medical Research and Opinion
|
July 25, 2017
Once-weekly oral antidiabetic agent and treatment satisfaction
Ira Gantz
American Journal of Physiology. Endocrinology and Metabolism
|
January 31, 2003
The melanocortin system
Ira Gantz, Tung M Fong
Obesity (Silver Spring, Md.)
|
March 31, 2006
Fat and energy partitioning: longitudinal observations in leptin-treated adults homozygous for a Lep mutation
Steven B Heymsfield, Tung M Fong, Ira Gantz, et al.
Diabetes, Obesity & Metabolism
|
March 26, 2021
Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin: A VERTIS CV substudy
Ildiko Lingvay, Michelle Greenberg, Silvina Gallo, et al.
Psychopharmacology
|
March 2, 2010
Randomized, controlled, double-blind trial of taranabant for smoking cessation
Mary F Morrison, Paulette Ceesay, Ira Gantz, et al.
The Journal of Biological Chemistry
|
March 26, 2002
Molecular determinants of human melanocortin-4 receptor responsible for antagonist SHU9119 selective activity
Yingkui Yang, Min Chen, Yumei Lai, et al.
Molecular Biology of the Cell
|
March 23, 2004
Inhibition of adipogenesis by ghrelin
Weizhen Zhang, Lili Zhao, Theodore R Lin, et al.
Molecular Pharmacology
|
June 20, 2003
Molecular determination of agouti-related protein binding to human melanocortin-4 receptor
Yingkui Yang, Min Chen, Yumei Lai, et al.
Annals of the New York Academy of Sciences
|
July 10, 2003
Loops and links: structural insights into the remarkable function of the agouti-related protein
Glenn L Millhauser, Joe C McNulty, Pilgrim J Jackson, et al.
Peptides
|
July 13, 2005
Chimeras of the agouti-related protein: insights into agonist and antagonist selectivity of melanocortin receptors
Pilgrim J Jackson, Bin Yu, Benjamin Hunrichs, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 63) with videos related to
Sort By:
Page
of 7
Current Medical Research and Opinion
|
July 25, 2017
Once-weekly oral antidiabetic agent and treatment satisfaction
Ira Gantz
American Journal of Physiology. Endocrinology and Metabolism
|
January 31, 2003
The melanocortin system
Ira Gantz, Tung M Fong
Obesity (Silver Spring, Md.)
|
March 31, 2006
Fat and energy partitioning: longitudinal observations in leptin-treated adults homozygous for a Lep mutation
Steven B Heymsfield, Tung M Fong, Ira Gantz, et al.
Diabetes, Obesity & Metabolism
|
March 26, 2021
Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin: A VERTIS CV substudy
Ildiko Lingvay, Michelle Greenberg, Silvina Gallo, et al.
Psychopharmacology
|
March 2, 2010
Randomized, controlled, double-blind trial of taranabant for smoking cessation
Mary F Morrison, Paulette Ceesay, Ira Gantz, et al.
The Journal of Biological Chemistry
|
March 26, 2002
Molecular determinants of human melanocortin-4 receptor responsible for antagonist SHU9119 selective activity
Yingkui Yang, Min Chen, Yumei Lai, et al.
Molecular Biology of the Cell
|
March 23, 2004
Inhibition of adipogenesis by ghrelin
Weizhen Zhang, Lili Zhao, Theodore R Lin, et al.
Molecular Pharmacology
|
June 20, 2003
Molecular determination of agouti-related protein binding to human melanocortin-4 receptor
Yingkui Yang, Min Chen, Yumei Lai, et al.
Annals of the New York Academy of Sciences
|
July 10, 2003
Loops and links: structural insights into the remarkable function of the agouti-related protein
Glenn L Millhauser, Joe C McNulty, Pilgrim J Jackson, et al.
Peptides
|
July 13, 2005
Chimeras of the agouti-related protein: insights into agonist and antagonist selectivity of melanocortin receptors
Pilgrim J Jackson, Bin Yu, Benjamin Hunrichs, et al.
Page
of 7